A large and growing body of undisputed evidence shows that ingredients produced from natural sources display a range of beneficial effects on human health. Health conscious consumers are increasingly aware of these benefits, for example; PACs and long chain polyphenols are clinically proven to inhibit viral infections. Market Research Media has conducted a study of Global Pandemic Influenza Preparedness Markets, their size, trends and drivers, principally for the countries with health expenditures per capita exceeding $2,000.

The results of this study found that since outbreaks of bird flu in 2005 and swine flu in 2009, the governments had recognized antiviral pandemic stockpiling as their preferred strategy for disease containment and mitigation. Since that time, the role of antiviral pandemic stockpiling has migrated across all branches of the healthcare systems and sub systems. Not surprisingly, the size of antiviral pandemic stockpiling spending has grown faster than the market overall.

Over the past five years, government spending worldwide on Pandemic Influenza Preparedness has more than tripled from $2.2 billion in 2004 to $7 billion in 2009, at a 17% CAGR. Market Research Media forecasts that worldwide government spending on Pandemic Influenza Preparedness will continue to grow, though at more moderate rate of a 5% CAGR, reaching almost $10 billion by 2015.
Abattis has obtained additional research from Frost and Sullivan and Nutrition Business Journal believe the current demand for alternative medicines from natural extracts will increase as health care industry costs increase.